Legal Problems in Psychiatric Drug Prescription
Abstract
Psychopharmacology is a relatively new treatment modality, and little legal precedent directly applicable to drug use in the office practice of psychotherapy exists. Because of growing concern among psychiatrists about legal risks in prescribing drugs, the author submitted a number of relevant questions to the Food and Drug Administration and a legal expert; the questions were also discussed at a law-drug conference at the Massachusetts Mental Health Center. The conclusions reached are discussed in this paper.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).